ELISA – News and Features

A simple blood test that detects IgG antibody aggregates, a biomarker for multiple sclerosis, with 90% accuracy could enhance MS diagnostics.

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.

A study of 500 health people has found that antibodies can develop against polyethylene glycol (PEG), a substance used in cosmetics, food and medicine, which might hinder the effectiveness of drugs.

This article explores the importance of testing for liver-related autoantibodies to differentiate between three autoimmune liver diseases.

Researchers discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The new molecules exploit the iron dependency of malignant cells.

Researchers reversed hearing loss in mice by restoring the function of a defective gene. The proof-of-concept study suggests that some types of hearing loss caused by reduced gene activity could be reversible.

Early diagnosis is likely to be essential in treating Alzheimer's disease. A team has demonstrated that tau PET - a novel imaging technique for visualizing the tau protein - can predict cognitive decline in patients much better than the imaging techniques normally used.

New study suggests harmful algal bloom toxicity varies over the summer.

A new nanoporous membrane allows highly efficient separation of wastewater components for reuse, offering industries sustainability and added-value benefits.

An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.